Focus on the role of NLRP3 inflammasome in the pathology of endometriosis: a review on molecular mechanisms and possible medical applications
- 21 December 2022
- journal article
- review article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 396 (4) , 621-631
Abstract
Endometriosis (EMS) is a gynecological disease that leads to pathological conditions, which are connected to the initiation of pro-inflammatory cytokine production. Inflammation plays a vital role in the pathogenesis of EMS. The activation and formation of cytoplasmic inflammasome complexes is considered an important step of inflammation and a key regulator of pyroptosis, a form of cell death. NLR family pyrin domain containing 3 (NLRP3) inflammasome complex modulates innate immune activity and inflammation. The NLRP3 inflammasome activates cysteine protease caspase-1, which produces active pro-inflammatory interleukins (ILs), including IL-1β and IL-18. The aim of this review article was to discuss the involvement of NLRP3 inflammasome assembly and its activation in the pathophysiology of EMS and target related pathways in designing appropriate therapeutic approaches. Dysregulation of sex hormone signaling pathways was associated with over-activation of the NLPR3 inflammasome. In this study, we demonstrated the involvement of NLRP3 inflammasome signaling pathways in the pathophysiology of EMS. The manuscript also discusses the beneficial effects of targeted therapy through synthetic inhibitors of NLRP3 signaling pathways to control EMS lesions.Keywords
This publication has 110 references indexed in Scilit:
- Angiogenesis and EndometriosisObstetrics and Gynecology International, 2013
- Distinct Licensing of IL-18 and IL-1β Secretion in Response to NLRP3 Inflammasome ActivationPLOS ONE, 2012
- Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosisFertility and Sterility, 2010
- Endometriosis and infertilityJournal of Assisted Reproduction and Genetics, 2010
- Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the InflammasomeJournal of Biological Chemistry, 2010
- Endometriosis - Morphology, clinical presentations and molecular pathologyJournal of Laboratory Physicians, 2010
- DAMPening Inflammation by Modulating TLR SignallingMediators of Inflammation, 2010
- The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesisNature Immunology, 2009
- Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosisThe FASEB Journal, 2007
- Peritoneal Cellular Immunity and EndometriosisAmerican Journal of Reproductive Immunology, 1997